Home LiteratureArticle Details
PMID: 21933918 Published · epublish English Journal Article Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.

mBio ·Vol. 2 ·No. 5 ·2011-00-00

Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Li Q, Kuestner RE, Ozinsky A, Taubenberger JK

Abstract

Secondary bacterial infections increase disease severity of influenza virus infections and contribute greatly to increased morbidity and mortality during pandemics. To study secondary bacterial infection following influenza virus infection, mice were inoculated with sublethal doses of 2009 seasonal H1N1 virus (NIH50) or pandemic H1N1 virus (Mex09) followed by inoculation with Streptococcus pneumoniae 48 h later. Disease was characterized by assessment of weight loss and survival, titration of virus and bacteria by quantitative reverse transcription-PCR (qRT-PCR), histopathology, expression microarray, and immunohistochemistry. Mice inoculated with virus alone showed 100% survival for all groups. Mice inoculated with Mex09 plus S. pneumoniae showed severe weight loss and 100% mortality with severe alveolitis, denuded bronchiolar epithelium, and widespread expression of apoptosis marker cleaved caspase 3. In contrast, mice inoculated with NIH50 plus S. pneumoniae showed increased weight loss, 100% survival, and slightly enhanced lung pathology. Mex09-S. pneumoniae coinfection also resulted in increased S. pneumoniae replication in lung and bacteremia late in infection. Global gene expression profiling revealed that Mex09-S. pneumoniae coinfection did not induce significantly more severe inflammatory responses but featured significant loss of epithelial cell reproliferation and repair responses. Histopathological examination for cell proliferation marker MCM7 showed significant staining of airway epithelial cells in all groups except Mex09-S. pneumoniae-infected mice. This study demonstrates that secondary bacterial infection during 2009 H1N1 pandemic virus infection resulted in more severe disease and loss of lung repair responses than did seasonal influenza viral and bacterial coinfection. Moreover, this study provides novel insights into influenza virus and bacterial coinfection by showing correlation of lethal outcome with loss of airway basal epithelial cells and associated lung repair responses. Secondary bacterial pneumonias lead to increased disease severity and have resulted in a significant percentage of deaths during influenza pandemics. To understand the biological basis for the interaction of bacterial and viral infections, mice were infected with sublethal doses of 2009 seasonal H1N1 and pandemic H1N1 viruses followed by infection with Streptococcus pneumoniae 48 h later. Only infection with 2009 pandemic H1N1 virus and S. pneumoniae resulted in severe disease with a 100% fatality rate. Analysis of the host response to infection during lethal coinfection showed a significant loss of responses associated with lung repair that was not observed in any of the other experimental groups. This group of mice also showed enhanced bacterial replication in the lung. This study reveals that the extent of lung damage during viral infection influences the severity of secondary bacterial infections and may help explain some differences in mortality during influenza pandemics.

MeSH Terms
Animals Coinfection/epidemiology,mortality Female Gene Expression Regulation Humans Influenza A Virus, H1N1 Subtype/pathogenicity,physiology Influenza, Human/microbiology,mortality,physiopathology,virology Lung/microbiology,physiopathology,virology Mice Mice, Inbred BALB C Pandemics Pneumococcal Infections/microbiology,mortality,physiopathology,virology Streptococcus pneumoniae/pathogenicity,physiology Virulence Weight Loss
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Kash John C
Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. kashj@niaid.nih.gov
Walters Kathie-Anne
Davis A Sally
Sandouk Aline
Schwartzman Louis M
Jagger Brett W
Chertow Daniel S
Li Qi
Kuestner Rolf E
Ozinsky Adrian
Taubenberger Jeffery K
References (32)
32 references, click to expand
  1. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.
    J Infect Dis. 2010 Oct 15;202(8):1287-95 PMID: 20822454
  2. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.
    Arch Pathol Lab Med. 2010 Feb;134(2):235-43 PMID: 20121613
  3. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice.
    J Virol. 2009 Apr;83(8):3754-61 PMID: 19211766
  4. New look at an old problem: bacterial superinfection after influenza.
    Am J Pathol. 2010 Feb;176(2):536-9 PMID: 20019194
  5. Role of Staphylococcus protease in the development of influenza pneumonia.
    Nature. 1987 Feb 5-11;325(6104):536-7 PMID: 3543690
  6. Planning for an influenza pandemic: thinking beyond the virus.
    J Infect Dis. 2008 Oct 1;198(7):945-7 PMID: 18710326
  7. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair.
    Am J Physiol Lung Cell Mol Physiol. 2002 May;282(5):L924-40 PMID: 11943656
  8. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.
    Comp Med. 2007 Feb;57(1):82-9 PMID: 17348295
  9. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques.
    J Virol. 2011 Feb;85(3):1214-23 PMID: 21084481
  10. Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung.
    Clin Exp Immunol. 2004 Jul;137(1):8-11 PMID: 15196237
  11. Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus.
    Microbiol Immunol. 1999;43(9):905-7 PMID: 10553684
  12. Pneumococcal pneumonia and influenza: a deadly combination.
    Vaccine. 2009 Aug 21;27 Suppl 3:C9-C14 PMID: 19683658
  13. Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation.
    Infect Immun. 1980 Feb;27(2):614-9 PMID: 6769805
  14. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.
    PLoS One. 2009 Dec 31;4(12):e8540 PMID: 20046873
  15. Postinfluenza bacterial pneumonia: host defenses gone awry.
    J Interferon Cytokine Res. 2010 Sep;30(9):643-52 PMID: 20726789
  16. Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia.
    Expert Rev Respir Med. 2008 Oct;2(5):663-72 PMID: 20477301
  17. Role of platelet-derived growth factor-B, vascular endothelial growth factor, insulin-like growth factor-II, mitogen-activated protein kinase and transforming growth factor-beta1 in expansion-induced lung growth in fetal sheep.
    Reprod Fertil Dev. 2006;18(6):655-65 PMID: 16930512
  18. Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.
    Am J Respir Cell Mol Biol. 2004 Dec;31(6):672-8 PMID: 15308506
  19. Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus.
    Influenza Other Respir Viruses. 2010 May 1;4(3):121-7 PMID: 20409208
  20. Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.
    Anesthesiology. 2007 Feb;106(2):252-61 PMID: 17264718
  21. Airway injury in lung disease pathophysiology: selective depletion of airway stem and progenitor cell pools potentiates lung inflammation and alveolar dysfunction.
    Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1256-65 PMID: 15298853
  22. Hydrophobic surfactant proteins and their analogues.
    Neonatology. 2007;91(4):303-10 PMID: 17575474
  23. Pathology of human influenza revisited.
    Vaccine. 2008 Sep 12;26 Suppl 4:D59-66 PMID: 19230162
  24. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.
    J Infect Dis. 2003 Mar 15;187(6):1000-9 PMID: 12660947
  25. Epithelial repair mechanisms in the lung.
    Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L715-31 PMID: 20363851
  26. Insights into the interaction between influenza virus and pneumococcus.
    Clin Microbiol Rev. 2006 Jul;19(3):571-82 PMID: 16847087
  27. Axis of coinfection evil.
    J Infect Dis. 2010 Feb 15;201(4):488-90 PMID: 20078214
  28. Pulmonary staphylococcal complications in patients during the influenza epidemic in 1971-1972.
    Mater Med Pol. 1974 Jul-Sep;6(3):207-12 PMID: 4280479
  29. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.
    Bull Hist Med. 2002 Spring;76(1):105-15 PMID: 11875246
  30. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.
    J Infect Dis. 2008 Oct 1;198(7):962-70 PMID: 18710327
  31. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
    J Infect Dis. 2002 Aug 1;186(3):341-50 PMID: 12134230
  32. Time from illness onset to death, 1918 influenza and pneumococcal pneumonia.
    Emerg Infect Dis. 2009 Feb;15(2):346-7 PMID: 19193293
Article Info
Journal
mBio
Abbr.
mBio
ISSN
2150-7511
Published
2011-00-00
Epub
2011-00-20
Language
English
Region
United States
NLM ID
101519231
PMCID
PMC3175626
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com